NOVORIG

Rapid Novor Inc.

Application Filed: 2020-08-13
Trademark Application Details
Trademark Logo NOVORIG

Status


630
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Research OneLook Acronym Finder
Serial Number90112581
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Docket Number0253429.0002

Timeline

2020-08-13Application Filed
2020-09-17Location: NEW APPLICATION PROCESSING
2020-09-17Status: Live/Pending
2020-09-17Transaction Date

Trademark Applicants & Owners

Owner: Rapid Novor Inc.
Address137 Glasgow St., Unit 450 Kitchener, Ontario CA N2G4X8
Legal Entity TypeCorporation
Legal Entity State CA

Documents

ApplicationMULTI2020-08-13
DrawingJPEG2020-08-13

Attorney of Record

RAPID NOVOR INC.
137 GLASGOW ST., UNIT 450
KITCHENER, ONTARIO
N2G4X8
CANADA

Good, Services, and Codes

International Codes:1
U.S. Codes:001,005,006,010,026,046
International Codes:5
U.S. Codes:005,006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0011Proteomics analysis test kits comprising reagents for detecting, quantifying and characterizing antibody proteins in a biological sample for scientific research purposes; Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune diseases and infections; Development of new technology for others in the field of biotechnology; Proteomics analysis services; Antibody profiling for scientific research purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals; Research and analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical laboratory services; Providing medical diagnostic and prognostic testing for cancer, autoimmune diseases and infections, and the analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2020-09-171 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER2020-12-082 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN2020-12-083 CNRT R:Renewal
NON-FINAL ACTION E-MAILED2020-12-084 GNRT F:First Action
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-12-085 GNRN O:Outgoing Correspondence
TEAS CHANGE OF OWNER ADDRESS RECEIVED2020-12-146 COAR I:Incoming Correspondence
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2020-12-147 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2020-12-148 ARAA I:Incoming Correspondence
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS2020-12-149 ECDR I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED2020-12-1410 TCCA I:Incoming Correspondence
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2020-12-1411 CHAN I:Incoming Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED2020-12-1612 TROA I:Incoming Correspondence
ASSIGNED TO LIE2021-03-1813 ALIE A:Allowance for Publication
CORRESPONDENCE RECEIVED IN LAW OFFICE2021-03-2314 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2021-03-2315 TEME I:Incoming Correspondence
ASSIGNED TO EXAMINER2021-04-1216 DOCK D:Assigned to Examiner
SUSPENSION LETTER WRITTEN2021-05-0517 CNSL R:Renewal
LETTER OF SUSPENSION E-MAILED2021-05-0518 GNSL S:
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED2021-05-0519 GNS3 O:Outgoing Correspondence
SUSPENSION INQUIRY WRITTEN2021-11-0520 CNSI R:Renewal
INQUIRY TO SUSPENSION E-MAILED2021-11-0521 GNSI S:
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED2021-11-0522 GNS2 O:Outgoing Correspondence
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED2022-05-0323 ERSI I:Incoming Correspondence
TEAS AMENDMENT OF USE RECEIVED2022-05-0324 EAAU I:Incoming Correspondence
TEAS REQUEST TO DIVIDE RECEIVED2022-05-0325 ERTD I:Incoming Correspondence
DIVISIONAL REQUEST RECEIVED2022-05-0326 DRRR I:Incoming Correspondence
DIVISIONAL PROCESSING COMPLETE2022-05-3127 DPCC D:Assigned to Examiner
DATA MODIFICATION COMPLETED2022-06-0128 DMCC I:Incoming Correspondence
SUSPENSION LETTER WRITTEN2022-06-0129 CNSL R:Renewal
LETTER OF SUSPENSION E-MAILED2022-06-0130 GNSL S:
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED2022-06-0131 GNS3 O:Outgoing Correspondence
SUSPENSION INQUIRY WRITTEN2022-12-1632 CNSI R:Renewal
INQUIRY TO SUSPENSION E-MAILED2022-12-1633 GNSI S:
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED2022-12-1634 GNS2 O:Outgoing Correspondence
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED2023-03-0335 ERSI I:Incoming Correspondence
ASSIGNED TO LIE2023-03-1036 ALIE A:Allowance for Publication
CORRESPONDENCE RECEIVED IN LAW OFFICE2022-05-0337 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2023-03-1338 TEME I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2023-03-1339 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2023-03-1340 TEME I:Incoming Correspondence
SUSPENSION LETTER WRITTEN2023-03-1341 CNSL R:Renewal
LETTER OF SUSPENSION E-MAILED2023-03-1342 GNSL S:
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED2023-03-1343 GNS3 O:Outgoing Correspondence
SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION2023-10-1744 RCCK S:
ASSIGNED TO EXAMINER2023-10-2345 DOCK D:Assigned to Examiner
SUSPENSION INQUIRY WRITTEN2023-10-2346 CNSI R:Renewal
INQUIRY TO SUSPENSION E-MAILED2023-10-2347 GNSI S:
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED2023-10-2348 GNS2 O:Outgoing Correspondence
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED2023-12-0649 ERSI I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE2023-12-0750 CRFA I:Incoming Correspondence
TEAS/EMAIL CORRESPONDENCE ENTERED2023-12-0751 TEME I:Incoming Correspondence
SUSPENSION LETTER WRITTEN2023-12-0852 CNSL R:Renewal
LETTER OF SUSPENSION E-MAILED2023-12-0853 GNSL S:
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED2023-12-0854 GNS3 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed